Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by JAKPUG4LIFEon Jun 17, 2020 9:13pm
49 Views
Post# 31162951

RE:RE:RE:RE:Form F10

RE:RE:RE:RE:Form F10Ranting is all that is left, than you wonder why there is no positives any more. Hey it was up 4% once today for about 30mins, nice!
Bigmac4000 wrote: Ya my thoughts are, I hate Graham lol. You must be a riot at parties lol. I'm just bugging. None of this is a total shock minus the timelines. We knew this drug was a 50 million dollar pig back in January or February. The timeline is the shock. I wish I kept cliffs notes on what I read sometimes. Didn't I read the whole dream of using the Australian company was they can fast track FDA results legally? Maybe I was wrong. Maybe it was just cheaper. I know the patent runs out in 2030. Why would anyone buy this by 2024 or even later. Would be ridiculous. Not to mention even if they did buy it, at what cost? I can see FSD selling it for what it cost just to put money back in the bank for the next great disaster. Oh and even bragging about it. I'm afraid I'm going to turn from a pessimistic realists to a full blown basher in about 24 hours. What a disgrace. From a 98.5% crash to the largest RS ever in the history of the CSE stock to going right back to a billion shares by 2025 probably. How many times can a company dilute and RS? Bet we will hold that record shortly also. Will be hard to average down when it'll be worth $0.12 cents. I can rant more but what's the point. FSD got paid already in stock and options so they don't care. All I'm doing is ranting to people in the same boat as me. Just brutal
GrahamB wrote:

Doing, Some back of the envelope calculations, FWIW.

 

If they complete phase 2 by Q1 of 2023 as they say, and then can apply for phase 3, the typical time span to complete phase 3, and submit an IND to the FDA, and then hopefully to get approved for marketing is about 6-7 years(posted the link before)

 

Now, knowing that they may well try to sell this to big Pharma  after phase 2, the question would be how much will they be able to get, recognizing that they would sell sometime in 2023, but big Pharma would then not have this drug approved until approximately 2029 or 2030.
 

The patent they have runs out around 2030

Thoughts?





Bullboard Posts